Medicated Skin Care in Mexico

Medicated Skin Care in Mexico

Euromonitor International's Medicated Skin Care in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
* Get a detailed picture of the medicated skin care industry
* Identify factors driving change
* Understand the competitive environment, the market’s major players and leading brands
* Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Medicated Skin Care in Mexico
Euromonitor International
September 2009
List of Contents and Tables
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value 2005-2008
Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 10 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
Bayer De México SA De Cv
Strategic Direction
Key Facts
Summary 1 Bayer de México SA de CV: Key Facts
Summary 2 Bayer de México SA de CV: Operational Indicators
Company Background
Production
Summary 3 Bayer de México SA de CV: Production Statistics 2007
Competitive Positioning
Summary 4 Bayer de México SA de CV: Competitive Position 2008
Boehringer Ingelheim Promeco SA De Cv
Strategic Direction
Key Facts
Summary 5 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 6 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2008
Farmacias Similares SA De Cv
Strategic Direction
Key Facts
Summary 8 Farmacias Similares SA de CV: Key Facts
Summary 9 Farmacias Similares SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Farmacias Similares SA de CV: Competitive Position 2008
Genomma Lab SA De Cv
Strategic Direction
Key Facts
Summary 11 Genomma Lab SA de CV: Key Facts
Summary 12 Genomma Lab SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 13 Genomma Lab SA de CV: Competitive Position 2008
GlaxoSmithKline Plc
Strategic Direction
Key Facts
Summary 14 GlaxoSmithKline México SA de CV: Key Facts
Summary 15 GlaxoSmithKline México SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 16 GlaxoSmithKline México SA de CV: Competitive Position 2008
Merck-méxico SA
Strategic Direction
Key Facts
Summary 17 Merck-México SA: Key Facts
Summary 18 Merck-México SA: Operational Indicators
Company Background
Competitive Positioning
Summary 19 Merck-México SA: Competitive Position 2008
Novartis Farmacéutica SA De Cv
Strategic Direction
Key Facts
Summary 20 Novartis Farmacéutica SA de CV: Key Facts
Summary 21 Novartis Farmacéutica SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 22 Novartis Farmacéutica SA de CV: Competitive Position 2008
Pfizer SA De Cv
Strategic Direction
Key Facts
Summary 23 Pfizer SA de CV: Key Facts
Summary 24 Pfizer SA de CV: Operational Indicators
Company Background
Competitive Positioning
Summary 25 Pfizer SA de CV: Competitive Position 2008
Procter & Gamble De México SA De Cv
Strategic Direction
Key Facts
Summary 26 Procter & Gamble de México SA de CV: Key Facts
Summary 27 Procter & Gamble de México SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 28 Procter & Gamble de México SA de CV: Competitive Position 2008
Wyeth SA De Cv
Strategic Direction
Key Facts
Summary 29 Wyeth SA de CV: Key Facts
Summary 30 Wyeth SA de CV: Operational Indicators
Company Background
Production
Summary 31 Wyeth SA de CV: Production Statistics 2007
Competitive Positioning
Summary 32 Wyeth SA de CV: Competitive Position 2008
Executive Summary
Sales of OTC Medication Grow at A Lower Pace
Mexican Regulations May Cause Abrupt Changes
Many Leading Positions Threatened by Emerging Industry Giant
Chained Outlets Are Taking Over the Distribution of Medications
Modest Growth Ahead
Key Trends and Developments
Mexican Regulation Seeking Quality and Affordability in Medications
Mexicans Like To Self-medicate
the Pharmaceutical Industry Faces Cost Pressures
Large Distributors of Medications Are Expanding Throughout Mexico
A Giant Is Making the OTC Industry Tremble
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 12 Life Expectancy at Birth 2003-2008
Market Data
Table 13 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 14 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 15 OTC Healthcare Company Shares by Value 2004-2008
Table 16 OTC Healthcare Brand Shares by Value 2005-2008
Table 17 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 18 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 19 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 20 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Definitions
Summary 33 Research Sources